Article Text
Statistics from Altmetric.com
QUESTION: In elderly people with hypertension, are newer antihypertensive drugs as effective as conventional antihypertensive drugs for reducing cardiovascular events?
Design
Randomised {allocation concealed*}†, blinded (outcome assessors),* controlled trial with 4 year follow up.
Setting
312 health centres in Sweden.
Patients
6614 patients who were 70 to 84 years of age (mean age 76 y, 67% women) and had hypertension (defined as systolic blood pressure ≥180 mm Hg or diastolic blood pressure ≥105 mm Hg or both). Follow up was 100%.
Intervention
Patients were allocated to 1 of 3 groups: conventional antihypertensive drugs (atenolol, 50 mg/d; metoprolol, 100 mg/d; pindolol, 5 mg/d; or fixed ratio hydrochlorothiazide, 25 mg/d, and amiloride, 2.5 mg/d) (n=2213); angiotensin converting enzyme (ACE) …
Footnotes
-
Sources of funding: Astra; Merck Sharp and Dohme; Sandoz; Zeneca.
-
For correspondence: Professor L Hansson, Department of Public Health and Social Sciences, University of Uppsala, PO Box 609, 75125 Uppsala, Sweden. Fax +46 18 177973.
↵† Information provided by author.